Split-luciferase complementation assay to detect channel-protein interactions in live cells.

The understanding of ion channel function continues to be a significant driver in molecular pharmacology. In this field of study, protein-protein interactions are emerging as fundamental molecular determinants of ion channel function and as such are becoming an attractive source of highly specific targets for drug development. The investigation of ion channel macromolecular complexes, however, still relies on conventional methods that are usually technically challenging and time-consuming, significantly hampering our ability to identify, characterize and modify ion channel function through targeted molecular approaches. As a response to the urgent need of developing rapid and albeit accurate technologies to survey ion channel molecular complexes, we describe a new application of the split-luciferase complementation assay to study the interaction of the voltage-gated Na + channel with the intracellular fibroblast growth factor 14 and its dynamic regulation in live cells. We envision that the flexibility and accessibility of this assay will have a broad impact in the ion channel field complementing structural and functional studies, enabling the interrogation of protein-channel dynamic interactions in complex cellular contexts and laying the basis for new frameworks in drug discovery campaigns.

[1]  J. Nerbonne,et al.  The FGF14F145S Mutation Disrupts the Interaction of FGF14 with Voltage-Gated Na+ Channels and Impairs Neuronal Excitability , 2007, The Journal of Neuroscience.

[2]  Giovanna Zinzalla,et al.  Targeting protein-protein interactions for therapeutic intervention: a challenge for the future. , 2009, Future medicinal chemistry.

[3]  K. Miura,et al.  Rapid and high-sensitivity cell-based assays of protein-protein interactions using split click beetle luciferase complementation: an approach to the study of G-protein-coupled receptors. , 2010, Analytical chemistry.

[4]  James Inglese,et al.  A specific mechanism for nonspecific activation in reporter-gene assays. , 2008, ACS chemical biology.

[5]  S. Stoilova-McPhie,et al.  Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex. , 2012, Assay and drug development technologies.

[6]  Raphael Kopan,et al.  Real-Time Imaging of Notch Activation with a Luciferase Complementation-Based Reporter , 2011, Science Signaling.

[7]  Francesco Saverio Pavone,et al.  Optical methods in the study of protein-protein interactions. , 2010, Advances in experimental medicine and biology.

[8]  Gary Matthews,et al.  Article Fibroblast Growth Factor Homologous Factors Control Neuronal Excitability through Modulation of Voltage-gated Sodium Channels , 2022 .

[9]  D. Piwnica-Worms,et al.  Luciferase Fragment Complementation Imaging of Conformational Changes in the Epidermal Growth Factor Receptor* , 2009, Journal of Biological Chemistry.

[10]  Harry Jubb,et al.  Structural biology and drug discovery for protein-protein interactions. , 2012, Trends in pharmacological sciences.

[11]  William A. Catterall,et al.  Signaling complexes of voltage-gated sodium and calcium channels , 2010, Neuroscience Letters.

[12]  John S Lazo,et al.  Building a Pharmacological Lexicon: Small Molecule Discovery in Academia , 2007, Molecular Pharmacology.

[13]  Paul B Bennett,et al.  High throughput ion-channel pharmacology: planar-array-based voltage clamp. , 2003, Assay and drug development technologies.

[14]  Christopher L. McClendon,et al.  Reaching for high-hanging fruit in drug discovery at protein–protein interfaces , 2007, Nature.

[15]  D. A. Thayer,et al.  Mechanisms of distribution and targeting of neuronal ion channels. , 2010, Current opinion in drug discovery & development.

[16]  Jin Zhang,et al.  Luminescent kinase activity biosensors based on a versatile bimolecular switch. , 2011, Journal of the American Chemical Society.

[17]  Kathryn E Luker,et al.  Optimizing luciferase protein fragment complementation for bioluminescent imaging of protein-protein interactions in live cells and animals. , 2004, Methods in enzymology.

[18]  Jason E. Gestwicki,et al.  Features of protein–protein interactions that translate into potent inhibitors: topology, surface area and affinity , 2012, Expert Reviews in Molecular Medicine.

[19]  J. Nerbonne,et al.  Fibroblast growth factor 14 is an intracellular modulator of voltage‐gated sodium channels , 2005, The Journal of physiology.

[20]  G. Terstappen.  Nonradioactive rubidium ion efflux assay and its applications in drug discovery and development. , 2004, Assay and drug development technologies.

[21]  Mustapha Samrakandi,et al.  Dual-color click beetle luciferase heteroprotein fragment complementation assays. , 2010, Chemistry & biology.

[22]  Jin Zhang,et al.  The cAMP-Dependent Protein Kinase Inhibitor H-89 Attenuates the Bioluminescence Signal Produced by Renilla Luciferase , 2009, PloS one.

[23]  Peter Buchwald,et al.  Small‐molecule protein–protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations , 2010, IUBMB life.

[24]  G. Erdemli,et al.  Ion channel drug discovery: challenges and future directions. , 2012, Future medicinal chemistry.

[25]  S S Gambhir,et al.  Noninvasive imaging of protein–protein interactions in living subjects by using reporter protein complementation and reconstitution strategies , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Jeffrey J Clare,et al.  Targeting ion channels for drug discovery. , 2010, Discovery medicine.